Pharmaceuticals, Biotechnology and Life Sciences
UK-based George Health will receive £27 million from three major investment partners to develop drug treatments and technologies for world’s…
Gerald Cagle, Ph.D. named Chairman of the Board Francine Behar-Cohen, M.D., Ph.D. named Chief Innovation Officer Thierry Bordet, Ph.D. named…
Kirin Holdings Hosted an Investor Day on March 3 to promote mutual understanding with the capital markets TOKYO–(BUSINESS WIRE)–Kirin Holdings…
– ACE-083 did not achieve statistically significant improvements in functional endpoints relative to placebo – – Acceleron to discontinue development…
46% Q4 revenue growth; 51% full year growth BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to…
– NDA for Ripretinib for the Treatment of Advanced GIST Accepted for Priority Review by U.S. FDA with PDUFA Date…
The collaboration will discover and develop up to 13 small molecule programs, initially targeting Pellino proteins to treat multiple indications…
The collaboration will discover and develop up to 13 small molecule programs, initially targeting Pellino proteins to treat multiple indications,…
CINCINNATI–(BUSINESS WIRE)–As coronavirus paralyzes the world with fear, bioscience enterprise The Gilla Company has developed and independently tested a product…
– Phase 3 Data from the BRAAVE 2020 Study in Black or African American Virologically Suppressed Adults Presented, Including Patients…